Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,812,468
in 11 filings, $79.8M under 10b5-1 plans

Net −$79,812,468. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-24 Calvin Sandra SVP, Chief Accounting Officer Sale −905 $21.90 $20K 35,028
2023-01-24 ROTE WILLIAM E. Senior Vice President, R&D Sale −2,062 $21.50 $44K 42,376
2023-01-24 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −2,062 $21.50 $44K 39,776
2023-01-24 Dube Eric M Chief Executive Officer Sale −6,442 $21.50 $139K 147,846
2023-01-24 Cline Christopher R. Chief Financial Officer Sale −852 $21.90 $19K 32,871
2023-01-24 Heerma Peter Chief Commercial Officer Sale −1,550 $21.90 $34K 63,598
2023-01-05 Dube Eric M Chief Executive Officer Sale −5,625 $20.75 $117K 154,288
2023-01-05 Inrig Jula Chief Medical Officer Sale −442 $20.75 $9K 17,507
2023-01-04 Inrig Jula Chief Medical Officer Sale −2,051 $20.75 $43K 17,949
2022-10-04 Heerma Peter Chief Commercial Officer Sale −3,042 $25.68 $78K 65,148
2022-09-13 Calvin Sandra SVP, Chief Accounting Officer Sale −349 $28.00 $10K 35,933
2022-09-01 Cline Christopher R. Chief Financial Officer Grant or award +5,000 33,723
2022-09-01 Cline Christopher R. Chief Financial Officer Grant or award · Employee Stock option (right to buy) +48,000 48,000
2022-09-01 Cline Christopher R. Chief Financial Officer Grant or award · Performance-based restricted stock units +9,840 9,840
2022-05-12 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −1,050 $21.51 $23K 41,838
2022-05-11 ROTE WILLIAM E. Senior Vice President, R&D Sale −750 $21.93 $16K 44,485
2022-05-11 ROTE WILLIAM E. Senior Vice President, R&D Sale −813 $21.52 $17K 43,672
2022-05-11 Clague Laura Chief Financial Officer Sale −1,375 $21.51 $30K 35,655
2022-05-11 Calvin Sandra SVP, Chief Accounting Officer Sale −445 $21.92 $10K 35,733
2022-05-11 Williams Brinkley Ruth Director Grant or award +3,000 8,250

Page 29 of 51 · 1,020 trades